Federal Register / Vol. 87, No. 15 / Monday, January 24, 2022 / Notices 3587 

Final ID in part. Specifically, the 

Commission determined to review the 

following issues: (1) The Final ID’s 

finding that the accused products satisfy 

the limitation ‘‘a second mode of 

operation comprising the low voltage 

event’’ of claims 1, 6, and 12 of the ’985 

patent; (2) the Final ID’s finding that the 

accused turbines having a doubly-fed 

induction generator (‘‘DFIG’’) satisfy the 

limitation ‘‘turbine controller causes the 

blade pitch control system to vary the 

pitch of the one or more blades’’ of 

claims 1, 6, and 12 of the ’985 patent; 

(3) the Final ID’s finding that certain 

full-converter turbines with later 

versions of software and DFIG Products 

infringe claims 29, 30, 33–35, and 37 of 

the ’985 patent; and (4) the Final ID’s 

finding that the accused products satisfy 

the limitation ‘‘during the entire 

duration of and subsequent to a zero 

voltage fault that lasts for an 

undetermined period of time’’ of claim 

1 of the ’705 patent. The Commission 

also determined to take no position on 

whether GE showed that the accused 

products satisfy the limitation ‘‘during 

the entire duration of and subsequent to 

a zero voltage fault that lasts for an 

undetermined period of time,’’ and 

therefore affirmed the Final ID’s finding 

of no violation as to claim 1 of the ’705 

patent based on 35 U.S.C. 101. The 

Commission did not review any other 

findings presented in the final ID. 

The Commission sought briefing from 

the parties on six issues and requested 

briefing from the parties, interested 

government agencies, and interested 

persons on remedy, bonding, and the 

public interest. On December 7, 2021, 

GE and SGRE filed their initial 

submissions in response to the 

Commission’s request for briefing. On 

December 14, 2021, GE and SGRE filed 

their reply submissions in response to 

the Commission’s request for briefing. 

The Commission also received 

submissions from U.S. Representative 

Paul Tonko; U.S. Representative 

William Timmons; Senator Patrick 

Leahy; Senator Tim Scott; Senators John 

Hoeven, Kevin Cramer, and Kelly 

Armstong; Senators Charles Grassley 

and Joni Ernst; Governor Kim Reynolds 

of Iowa; Governor Laura Kelly of 

Kansas; RWE Renewables Americas, 

LLC; Enel Green Power North America, 

Inc.; Avangrid Renewables, LLC; Allete 

Clean Energy; Clearway Energy Group, 

LLC; Algonquin Power & Utilities Corp.; 

and MidAmerican Energy Company. 

Having examined the record of this 

investigation, including the Final ID, the 

petitions for review, responses, and 

other submissions from the parties and 

the public, the Commission has 

determined that GE failed to show any 

accused SGRE products satisfies the 

limitation ‘‘a second mode of operation 

comprising the low voltage event’’ 

found in claims 1, 6, and 12 of the ’985 

patent. The Commission has further 

determined that GE failed to show that 

the accused SGRE DFIG products satisfy 

the limitation ‘‘turbine controller causes 

the blade pitch control system to vary 

the pitch of the one or more blades’’ of 

claims 1, 6, and 12 of the ’985 patent. 

Finally, the Commission finds that GE 

showed that the accused full-converter 

wind turbine generators with earlier 

versions of software infringe claims 29, 

30, 33–35, and 37 of the ’985 patent, but 

that GE did not show that the accused 

DFIG wind turbines generators or the 

accused full-converter wind turbine 

generators with later versions of 

software infringed those claims. The 

Commission therefore reverses the Final 

ID’s finding that SGRE infringes claims 

1, 6, and 12 of the ’985 patent, but finds 

that GE showed infringement of claims 

29, 30, 33–35, and 37 of the ’985 patent 

by the accused full-converter wind 

turbine generators with earlier versions 

of software. Accordingly, the 

Commission finds that GE has shown a 

violation of section 337 by SGRE with 

respect to claims 29, 30, 33–35, and 37 

of the ’985 patent. 

The Commission’s determinations are 

explained more fully in the 

accompanying Opinion. All other 

findings in the ID under review that are 

consistent with the Commission’s 

determinations are affirmed. 

The Commission has determined that 

the appropriate form of relief in this 

investigation is a limited exclusion 

order with respect to SGRE prohibiting 

the importation of certain variable speed 

wind turbine generators and 

components thereof that are covered by 

one or more of claims 29, 30, 33–35, and 

37 of the ’985 patent, and cease and 

desist orders that prohibits SGRE from 

further importing, selling, and 

distributing those products in the 

United States. The Commission has 

further determined that the public 

interest factors enumerated in 

subsection 337(d)(1) and (f)(1) (19 

U.S.C. 1337(d)(1) and (f)(1)) warrant an 

exemption in both orders for the service 

and repair of subject articles that were 

sold to U.S. consumers as of the date of 

the orders, but do not otherwise 

preclude the issuance of the limited 

exclusion order or the cease and desist 

orders. Finally, the Commission has 

determined that the bond for 

importation during the period of 

Presidential review shall be in the 

amount of zero percent (0%) (i.e., no 

bond) of the entered value of such 

articles. 

The Commission’s notice, order, and 

opinion were delivered to the President 

and to the United States Trade 

Representative on the day of their 

issuance. The Commission has also 

notified the Secretary of the Treasury 

and Customs and Border Protection of 

the order. The investigation is hereby 

terminated. 

The authority for the Commission’s 

determination is contained in section 

337 of the Tariff Act of 1930, as 

amended (19 U.S.C. 1337), and in part 

210 of the Commission’s Rules of 

Practice and Procedure (19 CFR part 

210). 

By order of the Commission. 

Issued: January 18, 2022. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2022–01234 Filed 1–21–22; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–875] 

Importer of Controlled Substances 

Application: Globyz Pharma, LLC; 

Correction 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application; 

correction. 

SUMMARY: The Drug Enforcement 

Administration (DEA) published a 

document in the Federal Register on 

August 12, 2021, concerning a notice of 

application. The document indicated 

the approved drug code (1205— 

Lisdexamfetamine) as a schedule I. The 

correct drug schedule should read 

schedule II. 

SUPPLEMENTARY INFORMATION: 

Correction 

In the Federal Register of August 12, 

2021, in FR Doc. 2021–17181 (86 FR 

44405), on page 44406, in the first 

column, in the controlled substance 

table, correct the drug schedule to 

schedule II. 

Brian S. Besser, 

Acting Assistant Administrator. 

[FR Doc. 2022–00852 Filed 1–21–22; 8:45 am] 

BILLING CODE P 


jspears on DSK121TN23PROD with NOTICES1